Macquarie resumed coverage of XPeng with a Neutral rating and $7 price target. While its mass-market launches will help, scale remains the biggest challenge for XPeng and the firm is concerned that heavy competition in its core BEV price segments make it difficult to grab share, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
